Neutrophil inhibitory factor prevents neutrophil-dependent lung injury - PubMed (original) (raw)

. 1995 Nov 15;155(10):4876-81.

Affiliations

PMID: 7594491

Neutrophil inhibitory factor prevents neutrophil-dependent lung injury

J W Barnard et al. J Immunol. 1995.

Abstract

Neutrophil inhibitory factor (NIF) is a recently cloned 41-kDa protein from the canine hookworm that binds CD11b/CD18 and inhibits CD11b/CD18-dependent neutrophil adhesion. We evaluated NIF's effects on neutrophil-dependent lung injury in guinea pigs. Pulmonary vascular endothelial CD54 (ICAM-1) was induced in buffer-perfused lungs by 90-min exposure to 1000 U/ml TNF-alpha. Human neutrophils (2 x 10(7)) were added to the perfusate and activated by 5 x 10(-9) PMA; in some lungs, the neutrophils were pretreated with NIF (100 nM) before their addition to the perfusate. Lung injury was assessed by wet:dry weight ratio, and neutrophil uptake by lung myeloperoxidase (MPO) activity. HUVEC exposed to TNF-alpha for 90 min were assayed for neutrophil adhesion, and we compared PMA-stimulated neutrophil adhesion to endothelial cells and fibrinogen-coated plates. PMA-induced pulmonary edema (lung wet:dry ratio increased from 8.8 +/- 0.7 to 18.8 +/- 4.4) was inhibited by NIF (10.0 +/- 1.0). Lung MPO activity concomitantly decreased from 17.1 +/- 6.1 to 8.7 +/- 1.8 U/mg dry lung tissue in the NIF-treated group, similar to controls (6.9 +/- 2.0). Endothelial monolayer experiments confirmed that NIF reduced neutrophil adherence (basal adhesion of 11 +/- 3% increased to 30 +/- 5% with TNF-alpha pretreatment of endothelial cells, an increase that was reduced to 10 +/- 4% with NIF). Moreover, NIF prevented PMA-induced neutrophil adhesion to fibrinogen, a CD11b/CD18-dependent event, but produced a smaller decrease in adherence to endothelial cells, which also involves CD11a/CD18 integrins. These studies indicate that NIF prevents neutrophil-dependent lung vascular injury by inhibiting neutrophil adhesion to the TNF-alpha-activated endothelium.

PubMed Disclaimer

Cited by

Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.
Veenstra AA, Tang J, Kern TS. Veenstra AA, et al. PLoS One. 2013 Oct 21;8(10):e78405. doi: 10.1371/journal.pone.0078405. eCollection 2013. PLoS One. 2013. PMID: 24205223 Free PMC article.
Neutrophil Activated by the Famous and Potent PMA (Phorbol Myristate Acetate).
Damascena HL, Silveira WAA, Castro MS, Fontes W. Damascena HL, et al. Cells. 2022 Sep 16;11(18):2889. doi: 10.3390/cells11182889. Cells. 2022. PMID: 36139464 Free PMC article. Review.
Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, Fyrst H, Saba J, Vogel SM, Malik AB, Mehta D. Tauseef M, et al. Circ Res. 2008 Nov 7;103(10):1164-72. doi: 10.1161/01.RES.0000338501.84810.51. Epub 2008 Oct 10. Circ Res. 2008. PMID: 18849324 Free PMC article.
Therapeutic targets to reduce the contribution of pulmonary neutrophilic inflammation towards obesity-associated co-morbidities: a mini-review.
Claveles Casas FN, Barrera FS, Lopez CM, Chacon I Del V, Di Sciullo MP, Ramirez DC, Gomez Mejiba SE. Claveles Casas FN, et al. Open J Pharm Sci Res. 2019;1(1):123-133. doi: 10.36811/ojpsr.2019.110006. Epub 2019 Aug 10. Open J Pharm Sci Res. 2019. PMID: 39450269 Free PMC article.
In vivo expression of neutrophil inhibitory factor via gene transfer prevents lipopolysaccharide-induced lung neutrophil infiltration and injury by a beta2 integrin-dependent mechanism.
Zhou MY, Lo SK, Bergenfeldt M, Tiruppathi C, Jaffe A, Xu N, Malik AB. Zhou MY, et al. J Clin Invest. 1998 Jun 1;101(11):2427-37. doi: 10.1172/JCI407. J Clin Invest. 1998. PMID: 9616214 Free PMC article.

Neutrophil inhibitory factor prevents neutrophil-dependent lung injury - PubMed (original) (raw)